Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $34.5000 (9.18%) ($33.0000 - $35.2000) on Wed. Oct. 5, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.76% (three month average) | RSI | 41 | Latest Price | $34.5000(9.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -5.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) ARKK(7%) PEJ(7%) VT(7%) XLF(7%) | Factors Impacting CAPR price | CAPR will decline at least -1.88% in a week (0% probabilities). TLT(-6%) IPO(-6%) VIXM(-5%) GLD(-5%) GDX(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.88% (StdDev 3.76%) | Hourly BBV | 0 () | Intraday Trend | 4.5% | | | |
|
1 - 5 Day Possible Target | $18.79(-45.54%) | Resistance Level | $35.38 | 5 Day Moving Average | $32.73(5.41%) | 10 Day Moving Average | $33.32(3.54%) | 20 Day Moving Average | $35.38(-2.49%) | To recent high | -19.2% | To recent low | 9.2% | Market Cap | $680m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |